RecruitingPhase 3NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Sponsor: H. Lundbeck A/S
New Haven, CT · Stamford, CT · Washington D.C., DC · +19 more sites
Phase 3 Migraine clinical trials
18 recruiting Phase 3 migraine studies in the US. What trial phases mean
Other phases
RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Birmingham, AL · Mobile, AL · Chandler, AZ · +110 more sites
RecruitingPhase 3NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Sponsor: Pfizer
Fort Smith, AR · Hawthorne, CA · La Mesa, CA · +53 more sites
RecruitingPhase 3NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Sponsor: H. Lundbeck A/S
New Haven, CT · Stamford, CT · Gainesville, FL · +17 more sites
RecruitingPhase 3NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Sponsor: H. Lundbeck A/S
Stamford, CT · Gulf Breeze, FL · Hialeah, FL · +12 more sites
RecruitingPhase 3NCT07729462
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
Sponsor: Pfizer
Scottsdale, AZ · Canoga Park, CA · Fresno, CA · +16 more sites
RecruitingPhase 3NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Glendale, AZ · Phoenix, AZ · +69 more sites
RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Huntsville, AL · Fayetteville, AR · Little Rock, AR · +29 more sites
RecruitingPhase 3NCT07629635
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
Sponsor: Columbia University
New York, NY
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Huntsville, AL · Saraland, AL · Little Rock, AR · +39 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Birmingham, AL · Scottsdale, AZ · Tempe, AZ · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Scottsdale, AZ · Tempe, AZ · Anaheim, CA · +112 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Huntsville, AL · Saraland, AL · Phoenix, AZ · +122 more sites
RecruitingPhase 3NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Birmingham, AL · Mobile, AL · Chandler, AZ · +110 more sites
RecruitingPhase 3NCT05598723
BOTOX® vs. XEOMIN® for Chronic Migraine
Sponsor: Naval Medical Center Camp Lejeune
Jacksonville, NC
RecruitingPhase 3NCT06641466
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Sponsor: Pfizer
Phoenix, AZ · Scottsdale, AZ · +29 more sites
RecruitingPhase 3NCT06904287
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
Sponsor: Wake Forest University Health Sciences
Oak Lawn, IL
Not yet recruitingPhase 3NCT06937385
0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment
Sponsor: HCA Florida North Florida Hospital
Gainesville, FL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.